SQZ News and Press, SQZ Biotechnologies Company From 03/08/21

SQZ Biotechnologies is a cell therapy manufacturing company developing its own pipeline of medicines. The investment thesis is centered around a large market opportunity to treat HPV+ solid tumors and the margin of safety provided by SQZ's sizable partnership with Roche. SQZ is a ...

SQZ Biotechnologies (NYSE:SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that Armon Sharei, PhD, chief executive officer of SQZ™, will present a corporate overview at the upcoming virtual H.C. Wainwright Global Life Scienc...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks finished modestly higher Friday on light pre-holiday volume following a late-session surge led by the energy sector, as crude oil futu...

SQZ Biotechnologies (NYSE: SQZ) fell by nearly 16% on Friday following the company's announcement of a new funding round. SQZ (pronounced "squeeze") is issuing 3 million new shares of common stock in an underwritten public offering that was priced Friday at $20 per share. This i...

Gainers: Artelo Biosciences (ARTL) +93%. ImmunoGen (IMGN) +29%. Prothena Corporation (PRTA) +26%. NantKwest (NK) +21%. Illumina (ILMN) +19%.Losers: Amicus Therapeutics (FOLD) -33%. CollPlant Biotechnologies (CLGN) -30%. Caladrius Biosciences (CLBS) -20%. Conformis (CFMS) -16%. SQZ Biotechnolo...

Gainers: Artelo Biosciences (ARTL) +82%.Wunong Net Technology Company (WNW) +72%.China Liberal Education Holdings (CLEU) +53%.ION Geophysical (IO) +42%.Top Ships (TOPS) +42%.Seanergy Maritime Holdings (SHIP) +34%.Luokung Technology (LKCO) +29%.ImmunoGen (IMGN) +29%.EuroDry (EDRY) +28%.Lizhi (...

SQZ Biotechnologies Company (SQZ) -5% premarket on pricing public offering of 3M common shares at $20/share.Underwriters' over-allotment is an additional 450K shares.Offering is expected to close on February 17. For further details see: SQZ Biotech stock down on $60M equity ra...

SQZ Biotechnologies Company (NYSE: SQZ) (“SQZ”), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the pricing of its underwritten public offering of 3,000,000 shares of common stock at a public offering price of $20.00 per ...

SQZ Biotechnologies (SQZ) announces that it has commenced an underwritten public offering of 3M shares.SQZ also expects to grant the underwriters a 30-day option to purchase up to an additional 450K shares.BofA Securities, Evercore ISI and Stifel are acting as joint book-running managers for ...

SQZ Biotechnologies Company (NYSE: SQZ) (“SQZ”), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that it has commenced an underwritten public offering of 3,000,000 shares of common stock. All of the shares of common stock ...